UBS Group’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.86M | Sell |
107,040
-265,613
| -71% | -$19.5M | ﹤0.01% | 2644 |
|
|
2025
Q1 | $42.6M | Buy |
372,653
+122,491
| +49% | +$14M | 0.01% | 1285 |
|
|
2024
Q4 | $12.6M | Buy |
250,162
+71,966
| +40% | +$3.63M | ﹤0.01% | 2144 |
|
|
2024
Q3 | $8.25M | Buy |
178,196
+11,819
| +7% | +$547K | ﹤0.01% | 1830 |
|
|
2024
Q2 | $5.41M | Sell |
166,377
-2,957
| -2% | -$96.1K | ﹤0.01% | 2071 |
|
|
2024
Q1 | $4.27M | Buy |
169,334
+36,300
| +27% | +$914K | ﹤0.01% | 2330 |
|
|
2023
Q4 | $4.32M | Buy |
133,034
+64,483
| +94% | +$2.09M | ﹤0.01% | 2133 |
|
|
2023
Q3 | $1.87M | Buy |
68,551
+20,627
| +43% | +$562K | ﹤0.01% | 2599 |
|
|
2023
Q2 | $1.07M | Buy |
47,924
+13,493
| +39% | +$300K | ﹤0.01% | 3249 |
|
|
2023
Q1 | $746K | Buy |
34,431
+3,106
| +10% | +$67.3K | ﹤0.01% | 3407 |
|
|
2022
Q4 | $636K | Sell |
31,325
-1,826
| -6% | -$37.1K | ﹤0.01% | 3502 |
|
|
2022
Q3 | $850K | Buy |
33,151
+995
| +3% | +$25.5K | ﹤0.01% | 2969 |
|
|
2022
Q2 | $764K | Sell |
32,156
-210,835
| -87% | -$5.01M | ﹤0.01% | 3063 |
|
|
2022
Q1 | $5.47M | Buy |
242,991
+3,415
| +1% | +$76.9K | ﹤0.01% | 1856 |
|
|
2021
Q4 | $4.74M | Buy |
239,576
+201,964
| +537% | +$4M | ﹤0.01% | 2139 |
|
|
2021
Q3 | $741K | Sell |
37,612
-63,820
| -63% | -$1.26M | ﹤0.01% | 3468 |
|
|
2021
Q2 | $2.23M | Buy |
101,432
+59,863
| +144% | +$1.32M | ﹤0.01% | 2656 |
|
|
2021
Q1 | $989K | Buy |
41,569
+621
| +2% | +$14.8K | ﹤0.01% | 3364 |
|
|
2020
Q4 | $1.07M | Sell |
40,948
-1,052
| -3% | -$27.5K | ﹤0.01% | 3103 |
|
|
2020
Q3 | $731K | Sell |
42,000
-90,304
| -68% | -$1.57M | ﹤0.01% | 3127 |
|
|
2020
Q2 | $2.23M | Sell |
132,304
-185,279
| -58% | -$3.12M | ﹤0.01% | 2195 |
|
|
2020
Q1 | $3.78M | Buy |
317,583
+57,166
| +22% | +$680K | ﹤0.01% | 1695 |
|
|
2019
Q4 | $3.15M | Buy |
260,417
+106,234
| +69% | +$1.29M | ﹤0.01% | 2384 |
|
|
2019
Q3 | $2.18M | Buy |
154,183
+3,074
| +2% | +$43.4K | ﹤0.01% | 2533 |
|
|
2019
Q2 | $1.69M | Buy |
151,109
+82,891
| +122% | +$924K | ﹤0.01% | 2646 |
|
|
2019
Q1 | $801K | Sell |
68,218
-38,194
| -36% | -$448K | ﹤0.01% | 3073 |
|
|
2018
Q4 | $1.42M | Buy |
106,412
+46,847
| +79% | +$626K | ﹤0.01% | 2717 |
|
|
2018
Q3 | $835K | Sell |
59,565
-36,237
| -38% | -$508K | ﹤0.01% | 3295 |
|
|
2018
Q2 | $1.51M | Buy |
95,802
+40,715
| +74% | +$640K | ﹤0.01% | 2757 |
|
|
2018
Q1 | $906K | Sell |
55,087
-3,501
| -6% | -$57.6K | ﹤0.01% | 3102 |
|
|
2017
Q4 | $1.06M | Sell |
58,588
-17,639
| -23% | -$319K | ﹤0.01% | 2983 |
|
|
2017
Q3 | $1.47M | Buy |
76,227
+10,153
| +15% | +$196K | ﹤0.01% | 2712 |
|
|
2017
Q2 | $779K | Sell |
66,074
-2,696
| -4% | -$31.8K | ﹤0.01% | 3079 |
|
|
2017
Q1 | $754K | Sell |
68,770
-13,397
| -16% | -$147K | ﹤0.01% | 3022 |
|
|
2016
Q4 | $596K | Buy |
82,167
+10,849
| +15% | +$78.7K | ﹤0.01% | 3189 |
|
|
2016
Q3 | $464K | Sell |
71,318
-86,010
| -55% | -$560K | ﹤0.01% | 3191 |
|
|
2016
Q2 | $859K | Buy |
157,328
+44,940
| +40% | +$245K | ﹤0.01% | 2816 |
|
|
2016
Q1 | $526K | Sell |
112,388
-23,612
| -17% | -$111K | ﹤0.01% | 3082 |
|
|
2015
Q4 | $677K | Buy |
136,000
+23,888
| +21% | +$119K | ﹤0.01% | 2947 |
|
|
2015
Q3 | $421K | Buy |
112,112
+1,168
| +1% | +$4.39K | ﹤0.01% | 3222 |
|
|
2015
Q2 | $667K | Sell |
110,944
-11,805
| -10% | -$71K | ﹤0.01% | 3068 |
|
|
2015
Q1 | $688K | Sell |
122,749
-11,829
| -9% | -$66.3K | ﹤0.01% | 3024 |
|
|
2014
Q4 | $403K | Buy |
+134,578
| New | +$403K | ﹤0.01% | 3325 |
|